Patents by Inventor Marianne Dragheim

Marianne Dragheim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic Uses of Compounds Having Combined Sert, 5-HT3 and 5-HT1a Activity
    Publication number: 20240082239
    Abstract: New pharmaceutical uses of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine and pharmaceutically acceptable salts thereof are provided.
    Type: Application
    Filed: April 4, 2023
    Publication date: March 14, 2024
    Applicant: H. Lundbeck A/S
    Inventors: Nicholas Moore, Marianne Dragheim
  • Therapeutic uses of compounds having combined sert, 5-HT3 and 5-HT1a activity
    Patent number: 11628166
    Abstract: New pharmaceutical uses of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine and pharmaceutically acceptable salts thereof are provided.
    Type: Grant
    Filed: May 12, 2020
    Date of Patent: April 18, 2023
    Assignee: H. Lundbeck A/S
    Inventors: Nicholas Moore, Marianne Dragheim
  • THERAPEUTIC USES OF 1-[2-(2,4-DIMETHYL-PHENYLSULFANYL)PHENYL]PIPERAZINE
    Publication number: 20220370439
    Abstract: The invention provides new therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]-piperazine and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: January 7, 2022
    Publication date: November 24, 2022
    Inventors: Marianne DRAGHEIM, Ioana FLOREA
  • Therapeutic Uses of Compounds Having Combined Sert, 5-HT3 and 5-HT1a Activity
    Publication number: 20210093631
    Abstract: New pharmaceutical uses of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine and pharmaceutically acceptable salts thereof are provided.
    Type: Application
    Filed: May 12, 2020
    Publication date: April 1, 2021
    Applicant: H. Lundbeck A/S
    Inventors: Nicholas Moore, Marianne Dragheim
  • THERAPEUTIC USES OF 1-[2-(2,4-DIMETHYL-PHENYLSULFANYL)PHENYL]PIPERAZINE
    Publication number: 20210085674
    Abstract: The invention provides new therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]-piperazine and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: May 18, 2020
    Publication date: March 25, 2021
    Inventors: Marianne DRAGHEIM, Ioana FLOREA
  • THERAPEUTIC USES OF 1-[2-(2,4-DIMETHYL-PHENYLSULFANYL)PHENYL]PIPERAZINE
    Publication number: 20190000836
    Abstract: The invention provides new therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]-piperazine and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: September 7, 2018
    Publication date: January 3, 2019
    Inventors: Marianne DRAGHEIM, Ioana FLOREA
  • Therapeutic Uses of Compounds Having Combined SERT, 5-HT3 and 5-HT1A Activity
    Publication number: 20180161321
    Abstract: New pharmaceutical uses of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine and pharmaceutically acceptable salts thereof are provided.
    Type: Application
    Filed: July 27, 2017
    Publication date: June 14, 2018
    Inventors: Nicholas Moore, Marianne Dragheim, Aneil Batra, Jin Chon
  • Therapeutic uses of compounds having combined SERT, 5-HTand 5-HTactivity
    Patent number: 9744166
    Abstract: New pharmaceutical uses of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine and pharmaceutically acceptable salts thereof are provided.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: August 29, 2017
    Assignee: H. Lundbeck A/S
    Inventors: Nicholas Moore, Marianne Dragheim
  • Therapeutic Uses of Compounds Having Combined SERT, 5-HT3 and 5-HT1A Activity
    Publication number: 20160228430
    Abstract: New pharmaceutical uses of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine and pharmaceutically acceptable salts thereof are provided.
    Type: Application
    Filed: February 12, 2016
    Publication date: August 11, 2016
    Inventors: Nicholas Moore, Marianne Dragheim
  • Therapeutic uses of compounds having combined SERT, 5-HTand 5-HTactivity
    Patent number: 9278096
    Abstract: New pharmaceutical uses of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine and pharmaceutically acceptable salts thereof are provided.
    Type: Grant
    Filed: November 12, 2008
    Date of Patent: March 8, 2016
    Assignees: H. Lundbeck A/S, Takeda Pharmaceuticals North America, Inc.
    Inventor: Marianne Dragheim
  • THERAPEUTIC USES OF 1-[2-(2,4-DIMETHYL-PHENYLSUFLANYL)PHENYL]PIPERAZINE
    Publication number: 20130184291
    Abstract: The invention provides new therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]-piperazine and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: August 22, 2011
    Publication date: July 18, 2013
    Applicant: H. LUNDBECK A/S
    Inventors: Marianne Dragheim, Ioana Florea
  • Therapeutic Uses Of Compounds Having Combined SERT, 5-HT3 And 5-HT1A Activity
    Publication number: 20110201617
    Abstract: New pharmaceutical uses of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine and pharmaceutically acceptable salts thereof are provided.
    Type: Application
    Filed: November 12, 2008
    Publication date: August 18, 2011
    Applicants: H. LUNDBECK A/S, TAKEDA PHARMACEUTICALS NORTH AMERICA, INC.
    Inventors: Nicholas Moore, Marianne Dragheim, Aneil Batra, Jin Chon